Sigyn Therapeutics Capital Expenditures (CapEx) Growth & History (SIGY)

Sigyn Therapeutics's capital expenditures (capex) was $860 for fiscal 2022.

View full Sigyn Therapeutics company overview

Sigyn Therapeutics annual capital expenditures (capex) history

Sigyn Therapeutics annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20222022-12-31$860−$28,404−97.06%
20212021-12-31$29,264
20182018-12-31$2,950$2,010+213.83%
20172017-12-31$940
20152015-12-31$2,451−$1,014−29.26%
20142014-12-31$3,465

Sigyn Therapeutics capital expenditures (capex) trends

Over the last five fiscal years, Sigyn Therapeutics's capital expenditures (capex) decreased from $940 to $860, a change of −$80. The latest reported quarter, Q3 2022, shows $1.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Sigyn Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about SIGY yet. Start the conversation.

Write the first post